查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1947980

全球機器人靜脈輸液配製系統市場（按最終用戶、應用、系統類型和組件分類）預測（2026-2032）

Robotic IV Compounding System Market by End User, Application, System Type, Component - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年機器人靜脈輸液系統市值為 3.1753 億美元，預計到 2026 年將成長至 3.4527 億美元，預計到 2032 年將達到 5.9957 億美元，複合年成長率為 9.50%。

關鍵市場統計數據
基準年 2025 3.1753億美元
預計年份：2026年 3.4527億美元
預測年份 2032 5.9957億美元
複合年成長率 (%) 9.50%

簡要介紹機器人靜脈輸液系統在現代醫療保健服務中的作用

自動化和機器人技術的進步正在重塑複雜靜脈輸液療法的配製方式，機器人靜脈輸液配藥系統正成為藥房服務安全性、準確性和營運穩定性的核心驅動力。這些系統將機械精度與軟體控制相結合，以減少人為錯誤、提高配藥的重複性並規範無菌操作技術。隨著腫瘤學、腸外營養和鎮痛治療等領域臨床需求的不斷成長，醫療機構不僅從合規性和安全性的角度評估自動化，而且將其視為產能規劃和人員最佳化的一種手段。

變革性變化正在重塑臨床環境中機器人靜脈輸液系統的實施和效能預期。

多種因素正在重塑機器人靜脈輸液系統的市場格局，這些因素影響系統的普及速度和性能預期。首先，醫療系統將用藥安全和減少錯誤列為優先事項，這為以機械化、檢驗的工作流程取代人工輸液方式提供了切實的動力。同時，機器人技術和視覺系統的進步提高了組件的可靠性，並實現了對劑量精度的更精確控制，從而提高了人們對自動化系統必須達到的標準。

評估2025年美國關稅變化對機器人靜脈輸液系統相關人員的累積營運和採購影響

美國近期關稅調整為採購計劃、供應商選擇以及諸如機器人靜脈輸液系統等資本設備的總體擁有成本評估帶來了新的變數。關稅變化不僅影響從海外進口的硬體組件（例如機械臂、視覺系統和專用感測器）的初始購置成本，還會影響備件定價和售後服務的經濟效益。這些變更迫使採購團隊重新評估供應商佈局，考慮在地採購策略，並更深入評估供應商支援網路。

從深入的細分觀點揭示了機器人靜脈輸液系統的最終用戶、應用、系統類型和組件生態系統的不同採用趨勢。

終端使用者的需求差異巨大：門診手術中心優先考慮的是容量和快速響應；癌症中心面臨著大量複雜的化療通訊協定，需要嚴格的劑量控制和檢驗；醫院需要能夠適應不同複雜程度的學術和社區醫療機構的解決方案；零售藥店需要在零售容量和配藥安全之間取得平衡；而專科藥店則專注於高度客製化的專科服務以及對專業操作的專業配藥。這些不同的優先事項影響採購標準和對供應商支援模式的預期。

區域層面深入分析機器人靜脈輸液系統的關鍵應用促進因素、監管影響和營運重點。

在美洲，醫療服務提供者優先考慮合規性、提高報銷效率以及與醫院資訊系統的整合，許多機構優先選擇能夠支援嚴格文件記錄和互通性的解決方案。醫療機構通常優先考慮供應商服務網路和響應迅速的本地支持，以確保無菌用品的持續供應。跨境貿易政策和供應鏈因素也會影響籌資策略，各機構都在尋求進口零件和本地服務能力之間的平衡。

從企業層面競爭考察，揭示供應商能力、服務模式和夥伴關係策略如何塑造機器人靜脈輸液生態系統。

供應商透過硬體創新、軟體整合能力以及深厚的服務和驗證體系來脫穎而出。市場領導通常提供成熟的硬體產品組合，包括經過驗證的機械臂、視覺系統和稱重組件，以及支援審核、電子批次記錄和與藥房資訊系統連接的軟體。此外，他們還提供全面的驗證服務、培訓計劃和強大的售後支持，從而降低機構在實施和持續營運過程中的風險。

業界領導者可應用以下實用建議，以加速安全、永續且經濟高效的機器人靜脈輸液系統的普及應用。

首先，要讓臨床、藥房和採購部門的相關人員圍繞通用目標達成一致，該目標優先考慮患者安全、工作流程效率和長期營運韌性。早期跨部門協作可以減少供應商評估過程中的誤解，並有助於更順暢的驗證和實施流程。接下來，進行能力映射，以確定需要優先自動化的藥房應用，例如化療、經腸營養和大容量鎮痛藥配製，並確定是採用整合平台還是專用的獨立系統。

我們對調查方法、資料來源和檢驗方法進行了透明的解釋，以得出有關機器人靜脈輸液系統的可操作見解。

本研究整合了來自一手定性研究、二手文獻、產品技術文件以及對臨床負責人、藥屋主任、採購負責人和供應商負責人的結構化訪談的發現。一手研究包括深入討論，旨在了解實際應用中的挑戰、服務模式預期以及監管合規要求。二手資訊包括與無菌配製和醫療設備互通性相關的監管指導文件和廣泛認可的技術標準。

針對機器人靜脈輸液系統的臨床安全性、營運彈性和策略採購影響，總結簡潔扼要的結論

機器人靜脈輸液系統被視為提升用藥安全性、提高流程一致性並解決藥局人員短缺問題的變革性工具。其應用需要採取綜合方法，將臨床需求與籌資策略和長期服務協議結合。相關人員可以透過決策來最大限度地發揮其優勢，這些決策應考慮特定應用的需求、整合式和獨立式系統結構之間的差異，以及可靠的檢驗和培訓資源的可用性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依最終用戶分類的機器人靜脈輸液配製系統市場

  • 門診手術中心
  • 癌症中心
  • 醫院
    • 大學醫院
    • 社區醫院
  • 零售藥房
  • 專科藥房

9. 依應用分類的機器人靜脈輸液配製系統市場

  • 緩解疼痛
  • 化療
  • 腸外營養

第10章 機器人靜脈輸液配藥系統市場（依系統類型分類）

  • 整合藥房自動化系統
  • 獨立系統

11. 機器人靜脈輸液配製系統市場（依組件分類）

  • 硬體
    • 條碼掃描器
    • 重力尺度
    • 機械臂
    • 視覺系統
  • 服務
  • 軟體

12. 各區域機器人靜脈輸液配製系統市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 機器人靜脈輸液配製系統市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國機器人靜脈輸液配藥系統市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

15. 美國機器人靜脈輸液配製系統市場

第16章：中國機器人靜脈輸液配藥系統市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • AmerisourceBergen Corporation
  • ARxIUM Inc.
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • Cerner Corporation
  • Fagron Sterile Services
  • ForHealth Technologies
  • Fresenius Kabi AG
  • Integrated Pharmacy Systems, LLC
  • Intelligen, Inc.
  • Kirby Lester LLC
  • KUKA AG
  • MedAvail Technologies, Inc.
  • Omnicell, Inc.
  • QFix GmbH
  • ScriptPro LLC
Product Code: MRR-4F7A6D4FB6BE

The Robotic IV Compounding System Market was valued at USD 317.53 million in 2025 and is projected to grow to USD 345.27 million in 2026, with a CAGR of 9.50%, reaching USD 599.57 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 317.53 million
Estimated Year [2026] USD 345.27 million
Forecast Year [2032] USD 599.57 million
CAGR (%) 9.50%

A concise, contextual introduction to the role of robotic IV compounding systems in modern healthcare delivery

Advances in automation and robotics are reshaping how complex intravenous therapies are prepared, with robotic IV compounding systems emerging as core enablers of safety, precision, and operational resilience within pharmacy services. These systems integrate mechanical precision with software control to reduce human error, improve repeatability of preparations, and standardize aseptic techniques. As clinical demands grow in oncology, parenteral nutrition, and analgesia, institutions increasingly evaluate automation not only for compliance and safety but also as an instrument of capacity planning and workforce optimization.

The interplay of regulatory scrutiny, stringent aseptic processing expectations, and rising complexity of therapy regimens has elevated compounding reliability to a strategic priority. In response, hospitals and specialty pharmacies are exploring comprehensive solutions that pair hardware such as robot arms, vision systems, and gravimetric scales with software that enables traceability and integration into electronic medication administration records. Transitional considerations include workflow redesign, staff training, and alignment with pharmacy quality assurance frameworks to fully realize gains in safety and throughput.

Across clinical settings, decision-makers must weigh capital allocation, service and maintenance models, and interoperability with existing automation platforms. These considerations drive a careful evaluation of integrated pharmacy automation systems versus standalone units, each presenting distinct trade-offs in scalability, vendor lock-in, and customization. Ultimately, robotic IV compounding systems are positioned as pivotal investments that support enhanced clinical outcomes, operational continuity, and stronger alignment between pharmacy operations and broader institutional safety goals.

Transformative shifts reshaping adoption and performance expectations for robotic IV compounding systems across clinical environments

The landscape for robotic IV compounding systems is being reshaped by converging forces that affect adoption velocity and performance expectations. First, healthcare systems are prioritizing medication safety and error reduction, creating a practical impetus to replace manual compounding methods with mechanized, validated workflows. In tandem, advances in robotics and vision systems have improved component reliability and enabled more refined control over dosing accuracy, which in turn raises the baseline expectations for what automation should deliver.

Secondly, integration capabilities have progressed, enabling tighter connectivity between compounding systems and pharmacy information systems, thereby facilitating electronic documentation, audit trails, and more efficient reconciliation processes. This integration reduces administrative burden and strengthens compliance posture, while also supporting analytics-driven process improvements. Thirdly, service delivery models are evolving as vendors extend lifecycle support through remote diagnostics, predictive maintenance, and subscription-style service offerings that shift certain risks from buyers to suppliers.

Regulatory emphasis on sterile compounding practices and heightened scrutiny following high-profile incidents have further accelerated the transition toward automated solutions that offer reproducible aseptic environments and rigorous verification mechanisms. Finally, workforce dynamics, including shortages of trained compounding pharmacists and technicians, are driving organizations to consider automation as a strategic lever to maintain capacity and refocus skilled staff on clinical oversight and patient-centered activities. Taken together, these shifts are elevating expectations regarding system interoperability, validation support, and long-term service commitments.

Assessing the cumulative operational and procurement implications of United States tariff changes in 2025 for robotic IV compounding system stakeholders

Recent tariff adjustments in the United States have introduced new variables into procurement planning, supplier selection, and total cost of ownership assessments for capital equipment such as robotic IV compounding systems. Tariff changes affect not only the upfront acquisition cost of hardware components imported from overseas, including robot arms, vision systems, and specialized sensors, but also influence spare parts pricing and aftermarket service economics. These shifts compel purchasing teams to reassess supplier footprints, consider localized sourcing strategies, and evaluate vendor support networks more closely.

Consequently, stakeholders are examining supply chain resilience with heightened scrutiny. Organizations are prioritizing vendors with diversified manufacturing bases or strong domestic service infrastructures to mitigate potential tariff-driven price volatility. Contract negotiations increasingly incorporate clauses addressing tariff pass-through, lead time protections, and contingency plans for parts obsolescence. Procurement teams are also working more closely with clinical and finance leaders to model the operational trade-offs of selecting integrated automation platforms versus modular or standalone systems that may offer different exposure to imported components.

In addition, maintenance agreements and spare parts inventories are being re-evaluated to reduce vulnerability to cross-border cost fluctuations. Some institutions are allocating contingency budgets for aftermarket support or negotiating bundled service contracts to stabilize long-term cost commitments. These strategic responses reflect a broader emphasis on supply chain transparency, vendor accountability, and risk-sharing arrangements that maintain clinical continuity and protect capital investments against external tariff pressures.

Insightful segmentation perspectives that illuminate distinct adoption dynamics across end users, applications, system types, and component ecosystems for robotic IV compounding systems

End user dynamics vary widely: ambulatory surgical centers prioritize throughput and quick turnaround, cancer centers face high volumes of complex chemotherapy protocols that demand stringent dose control and verification, hospitals require scalable solutions across both academic medical centers and community hospitals with differing levels of operational sophistication, retail pharmacies balance retail throughput with compounding safety, and specialty pharmacies focus on highly customized preparations and adherence to specialized handling standards. These divergent priorities shape procurement criteria and expected vendor support models.

Application-driven differentiation is equally significant, as analgesia compounding requires fast, safe handling of frequently administered preparations with robust verification steps, chemotherapy compounding hinges on containment, cytotoxic handling protocols, and cross-contamination controls, while parenteral nutrition formulations demand precise volumetric and gravimetric control to ensure nutrient balance and patient safety. Each application imposes distinct validation, training, and environmental control requirements that influence system selection and process redesign.

System type decisions pivot on whether organizations choose integrated pharmacy automation systems that offer comprehensive ecosystem-level interoperability and centralized control versus standalone systems that can be deployed incrementally to address specific bottlenecks. Finally, the component-level landscape encompasses hardware, services, and software, with hardware elements such as barcode scanners, gravimetric scales, robot arms, and vision systems forming the physical backbone, services encompassing installation, validation, and lifecycle support, and software enabling workflow orchestration, traceability, and systems integration to complete a compliant compounding solution.

Regional insights that clarify adoption drivers, regulatory influences, and operational priorities across major global geographies for robotic IV compounding systems

In the Americas, healthcare providers emphasize regulatory compliance, reimbursement-driven efficiency, and integration with hospital information systems, prompting many institutions to prioritize solutions that support rigorous documentation and interoperability. Facilities often focus on vendor service networks and rapid on-site support to maintain continuous sterile production. Cross-border trade policies and supply chain considerations also inform procurement strategies, with organizations seeking balanced approaches between imported components and local service capabilities.

Within Europe, the Middle East & Africa region, regulatory frameworks and national standards vary considerably, which drives a preference for configurable systems that can meet diverse compliance requirements. In parts of Europe, stringent aseptic processing regulations and centralized procurement can favor larger integrated systems, while in certain markets in the Middle East and Africa, adoption is influenced by infrastructure readiness, local maintenance capacity, and capital availability. Vendors pursuing these markets often adapt service models and training programs to accommodate regional heterogeneity.

Asia-Pacific presents a mix of rapid adoption in advanced urban centers and emerging demand in markets building clinical infrastructure. Stakeholders in leading economies prioritize high-throughput automation and advanced analytics to support large-volume oncology and tertiary care settings, whereas other markets focus on scalable, cost-effective solutions that balance automation benefits with budgetary constraints. Across all regions, local training, validation capacity, and vendor aftercare remain central determinants of successful deployment and long-term operational sustainability.

Key competitive and collaborative company-level insights that reveal how vendor capabilities, service models, and partnership strategies shape the robotic IV compounding ecosystem

Vendors differentiate themselves through a combination of hardware innovation, software integration capabilities, and the depth of their service and validation offerings. Market leaders often bring mature hardware portfolios with proven robot arms, vision systems, and gravimetric components, coupled with software that supports audit trails, electronic batch records, and connectivity to pharmacy information systems. These capabilities are reinforced by comprehensive validation services, training programs, and robust aftermarket support that reduce institutional risk during deployment and ongoing operations.

Strategic partnerships between technology providers, system integrators, and clinical advisory bodies have become common, enabling faster implementation and more credible validation pathways. Some companies focus on modular solutions that allow phased adoption, while others emphasize fully integrated platforms designed for enterprise-wide standardization. Service differentiation is frequently expressed through advanced maintenance models, remote diagnostics, and tailored training curricula that shorten ramp-up times and improve system uptime.

Competitive dynamics also reflect a focus on interoperability, with vendors investing in open APIs and standardized communication protocols to reduce integration friction with existing pharmacy ecosystems. Additionally, companies that demonstrate strong regulatory support, including documentation and validation toolkits, tend to be preferred by institutions with high compliance expectations. Ultimately, procurement decisions hinge on a vendor's ability to deliver a balanced proposition of proven hardware, adaptable software, and predictable service delivery.

Actionable recommendations that industry leaders can apply to accelerate safe, sustainable, and cost-effective adoption of robotic IV compounding systems

Begin by aligning clinical, pharmacy, and procurement stakeholders around shared objectives that prioritize patient safety, workflow efficiency, and long-term operational resilience. Early cross-functional engagement reduces misalignment during vendor evaluation and facilitates a smoother validation and implementation process. Next, conduct a capability mapping exercise to identify which compounding applications-such as chemotherapy, parenteral nutrition, or high-volume analgesia-require prioritized automation, thereby informing whether to pursue integrated platforms or targeted standalone systems.

Prioritize vendors that demonstrate clear interoperability roadmaps and provide strong validation and training support. Evaluate service models not only for initial installation but for predictable lifecycle maintenance, remote diagnostic capabilities, and parts availability. To mitigate external supply chain and tariff-related risks, favor vendors with diversified manufacturing footprints or robust local service ecosystems. Additionally, incorporate structured change management programs that include competency-based training, documented standard operating procedures, and staged acceptance testing to ensure safe transition of compounding activities.

Finally, embed continuous improvement by establishing performance metrics tied to safety, throughput, and downtime, and leverage vendor partnerships to analyze data and optimize processes. These steps collectively reduce implementation risk, improve clinical outcomes, and create a foundation for scalable automation across pharmacy services.

A transparent explanation of research methodology, data sources, and validation practices used to generate actionable insights for robotic IV compounding systems

This research synthesizes insights from a combination of primary qualitative engagements, secondary public-domain literature, product technical documentation, and structured interviews with clinical leaders, pharmacy directors, procurement professionals, and vendor representatives. Primary engagements involved in-depth discussions to understand real-world deployment challenges, service model expectations, and regulatory compliance needs. Secondary sources included regulatory guidance documents and widely accepted technical standards relevant to sterile compounding and medical device interoperability.

Data triangulation methods were applied to cross-validate themes that emerged during interviews with available technical specifications and vendor materials. Validation steps included follow-up interviews to refine understanding of implementation timelines and service continuity strategies. Where applicable, vendor-provided validation protocols and installation narratives were reviewed to assess the practicalities of commissioning and ongoing maintenance. The methodology emphasizes transparency in source types and applies critical appraisal to reconcile differing perspectives and identify convergent themes.

Stakeholder confidentiality and anonymization protocols were observed for all primary engagements to ensure candid feedback. The resulting analysis focuses on operational and strategic implications rather than proprietary performance claims, making the findings applicable to clinical and procurement audiences seeking practical guidance for system selection and implementation.

A concise conclusion that synthesizes implications for clinical safety, operational resilience, and strategic procurement of robotic IV compounding systems

Robotic IV compounding systems are positioned as transformative tools that enhance medication safety, improve process consistency, and address workforce constraints within pharmacy operations. Their adoption requires a holistic approach that aligns clinical imperatives with procurement strategies and long-term service commitments. Stakeholders benefit most when decisions account for application-specific requirements, differences between integrated and standalone system architectures, and the availability of robust validation and training resources.

Operational resilience depends on selecting vendors with reliable hardware, interoperable software, and proven service frameworks, particularly in the context of supply chain variability and evolving regulatory expectations. Successful implementation hinges on cross-functional planning, staged deployment, and continuous monitoring against safety and performance metrics. By applying disciplined procurement practices and structured change management, healthcare organizations can realize the dual goals of enhancing patient safety and optimizing operational efficiency through targeted automation.

The strategic imperative for organizations is to approach automation adoption with a balance of ambition and pragmatism, ensuring that investments translate into measurable improvements in compounding reliability, staff utilization, and overall quality of care.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Robotic IV Compounding System Market, by End User

  • 8.1. Ambulatory Surgical Centers
  • 8.2. Cancer Centers
  • 8.3. Hospitals
    • 8.3.1. Academic Medical Centers
    • 8.3.2. Community Hospitals
  • 8.4. Retail Pharmacies
  • 8.5. Specialty Pharmacies

9. Robotic IV Compounding System Market, by Application

  • 9.1. Analgesia
  • 9.2. Chemotherapy
  • 9.3. Parenteral Nutrition

10. Robotic IV Compounding System Market, by System Type

  • 10.1. Integrated Pharmacy Automation Systems
  • 10.2. Standalone Systems

11. Robotic IV Compounding System Market, by Component

  • 11.1. Hardware
    • 11.1.1. Barcode Scanners
    • 11.1.2. Gravimetric Scales
    • 11.1.3. Robot Arms
    • 11.1.4. Vision Systems
  • 11.2. Services
  • 11.3. Software

12. Robotic IV Compounding System Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Robotic IV Compounding System Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Robotic IV Compounding System Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Robotic IV Compounding System Market

16. China Robotic IV Compounding System Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. AmerisourceBergen Corporation
  • 17.6. ARxIUM Inc.
  • 17.7. Baxter International Inc.
  • 17.8. Becton, Dickinson and Company
  • 17.9. Cerner Corporation
  • 17.10. Fagron Sterile Services
  • 17.11. ForHealth Technologies
  • 17.12. Fresenius Kabi AG
  • 17.13. Integrated Pharmacy Systems, LLC
  • 17.14. Intelligen, Inc.
  • 17.15. Kirby Lester LLC
  • 17.16. KUKA AG
  • 17.17. MedAvail Technologies, Inc.
  • 17.18. Omnicell, Inc.
  • 17.19. QFix GmbH
  • 17.20. ScriptPro LLC

LIST OF FIGURES

  • FIGURE 1. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY CANCER CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY CANCER CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY CANCER CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY ACADEMIC MEDICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SPECIALTY PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SPECIALTY PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY ANALGESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY ANALGESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY ANALGESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY CHEMOTHERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY CHEMOTHERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY CHEMOTHERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY INTEGRATED PHARMACY AUTOMATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY INTEGRATED PHARMACY AUTOMATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY INTEGRATED PHARMACY AUTOMATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY STANDALONE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY BARCODE SCANNERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY BARCODE SCANNERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY BARCODE SCANNERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY GRAVIMETRIC SCALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY GRAVIMETRIC SCALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY GRAVIMETRIC SCALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY ROBOT ARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY ROBOT ARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY ROBOT ARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY VISION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY VISION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY VISION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 130. GCC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GCC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 132. GCC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 133. GCC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. GCC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. GCC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 136. GCC ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 151. G7 ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. G7 ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. G7 ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 154. G7 ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 155. G7 ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. G7 ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 157. G7 ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 158. NATO ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. NATO ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. NATO ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 161. NATO ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 162. NATO ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. NATO ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 164. NATO ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA ROBOTIC IV COMPOUNDING SYSTEM MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)